510(k) device
Pathfinder Endoscope Overtube
Neptune Medical, Inc. · Endoscopic Access Overtube, Gastroenterology-Urology (FED, Class II) · First FDA decision Aug 30, 2019, newest Sep 18, 2026Kidney stones
Last checked: Nov 21, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
510(k) pathway
Device trials
10
Naming "Pathfinder"
MAUDE reports
29
Brand "Pathfinder", since 2015
PubMed studies
825
Mentioning "Pathfinder"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Pathfinder Endoscope Overtube
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
K262262 · Decided Sep 18, 2026 · 78 days after receipt
Device type: Endoscopic Access Overtube, Gastroenterology-Urology (FED) · GI, Urology & Nephrology
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Pathfinder", any status and sponsor, newest update first.
- Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid RegurgitationPivotal-lookingRecruiting
Medtronic CardiovascularPublic (MDT)
NCT07321899 · 1,186 participants (planned) · Start Sep 11, 2026 · Primary completion Sep 2031
Device: Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System; Edwards EVOQUE Tricuspid Valve Replacement (TTVR) System · For: Severe Tricuspid Regurgitation
Sites: Birmingham, Alabama; Phoenix, Arizona; Los Angeles, California · 20 sites in all
9 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Pathfinder", and for the whole product code for context.
This brand
29 reports: 14 malfunction, 14 injury, 1 death
Whole product code FED
605 reports: 419 malfunction, 169 injury, 15 death
Newest reports for this brand
- INCOMPASS/PATHFINDER TWO-PRONG BITMalfunction
3012447612-2026-00137 · Received May 26, 2026 · Event dated Apr 26, 2026
Device type: Bit, Drill (HTW)
Device problem as coded: Fracture
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Pathfinder"[tiab]. The summary above synthesizes these.
- Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study.
Schrag D, Beer TM, McDonnell CH, et al. · Lancet · 2023Research Support, Non-U.S. Gov't
- Pathfinder: Protein folding pathway prediction based on conformational sampling.
Huang Z, Cui X, Xia Y, et al. · PLoS Comput Biol · 2023Research Support, Non-U.S. Gov't
- Avapritinib for advanced systemic mastocytosis.
Gotlib J, Reiter A, DeAngelo DJ · Blood · 2022
- PATHFINDER: Designing Stimulus for Neuromodulation Through Data-Driven Inverse Estimation of Non-Linear Functions.
Goswami C, Grover P · IEEE Trans Biomed Eng · 2023Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't
- Oman, a Pathfinder Towards Tuberculosis Elimination: The journey begins.
Al Yaquobi F, Al-Abri S · Sultan Qaboos Univ Med J · 2022Editorial
- Evaluating eligibility criteria of oncology trials using real-world data and AI.
Liu R, Rizzo S, Whipple S, et al. · Nature · 2021Research Support, N.I.H., Extramural
- PATHFINDER: another step on the uncharted path to multicancer screening.
Lee R, Robbins HA · Lancet · 2023Comment
- A pathfinder.
Rider HE · J Am Vet Med Assoc · 1991Autobiography, Biography
- PathFinder: Bayesian inference of clone migration histories in cancer.
Kumar S, Chroni A, Tamura K, et al. · Bioinformatics · 2020Research Support, N.I.H., Extramural
- Pathfinder: open source software for analyzing spatial navigation search strategies.
Cooke MB, O'Leary TP, Harris P, et al. · F1000Res · 2019Research Support, Non-U.S. Gov't
- PathfinderৄNavigating and Analyzing Chemical Reaction Networks with an Efficient Graph-Based Approach.
Türtscher PL, Reiher M · J Chem Inf Model · 2023Research Support, Non-U.S. Gov't
- Molecular Autonomous Pathfinder Using Deep Reinforcement Learning.
Nomura KI, Mishra A, Sang T, et al. · J Phys Chem Lett · 2024
Other devices of this type
Also filed under product code FED.
- Navigator HD Ureteral Access Sheath Set 11/13 F x 28cm (M0062502210)Boston Scientific Corporation · 510(k) 2025
- Re-Trace Ureteral Access Sheath, 12/14 Ch/Fr, Length 35 Cm, Length 45 CmColoplast A/S · 510(k) 2014
- Single Use Ureteral Access SheathZhejiang Chuangxiang Medical Technology Co., Ltd. · 510(k) 2026
- CVAC Aspiration SystemCalyxo, Inc. · 510(k) 2026
- Single-use Ureteral Access SheathHunan Vathin Medical Instrument Co., Ltd. · 510(k) 2025
- ClearPetra Suction-Evacuation SheathWell Lead Medical Co., Ltd. · 510(k) 2020
- Arc EndoCuff and Arc EndoCuff VisionBoddingtons Plastics, Ltd. · 510(k) 2016
- Barosense Endogastric Tube and Introducer BougieBarosense, Inc. · 510(k) 2012
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.